Keyphrases
Critically Ill children
81%
Consensus Conference
55%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
52%
Transfusion
44%
Bleeding
43%
Pediatric
38%
Cardiac Surgery
30%
Pediatric Patients
28%
Platelet Transfusion
27%
Hemostasis
26%
Thrombosis
24%
Critical Care
22%
Anticoagulation
21%
Anemia
21%
Pediatric Extracorporeal Membrane Oxygenation
20%
Storage Duration
19%
Perioperative Care
18%
Plasma Transfusion
18%
Red Blood Cells
18%
Clinical Outcomes
17%
Platelets
16%
Organ Dysfunction
15%
Ventricular Assist Device
14%
Cardiopulmonary Bypass
13%
Hematopoietic Cell Transplant
13%
Pediatric Intensive Care Unit
13%
Collaborative Consensus
12%
International Society
12%
Sepsis
11%
Embase
11%
Consensus Statement
10%
Clinical Trials
10%
Berlin Heart
10%
Extracorporeal Membrane Oxygenation Support
10%
Acute Lymphoblastic Leukemia
10%
Neonate
10%
Multiple Organ Dysfunction Syndrome
10%
Improved Outcomes
10%
Hematopoietic Cell Transplantation
10%
Randomized Controlled Trial
10%
Red Blood Cell Storage
9%
Pediatric Ventricular Assist Device
9%
Transfusion Practice
9%
Transfusion Strategy
9%
Bone Marrow Transplantation
9%
Executive Summary
9%
RBC Transfusion
9%
Pediatric Critical Care
9%
Oncologic
8%
PubMed
8%
Medicine and Dentistry
Pediatrics
100%
Extracorporeal Membrane Oxygenation
61%
Bleeding
56%
Intensive Care
43%
Heart Surgery
37%
Erythrocyte
32%
Thrombocyte Transfusion
31%
Platelet
30%
Blood Stasis
27%
Pediatrics Patient
26%
Thrombosis
24%
Ventricular Assist Device
22%
Anticoagulation
21%
Anemia
21%
Hematopoietic Cell
19%
Perioperative Period
18%
Plasma Transfusion
18%
Hemostat
16%
Hematopoietic Stem Cell Transplantation
14%
Erythrocyte Preservation
14%
Intensive Care Unit
14%
Diseases
14%
Clinical Trial
13%
Neonates
13%
Antithrombotic
12%
Cardiopulmonary Bypass
12%
Systematic Review
12%
Heparin
11%
Acute Lymphoblastic Leukemia
11%
Sepsis
11%
Multiple Organ Dysfunction Syndrome
10%
Randomized Controlled Trial
10%
Neoplasm
10%
Cell Transplantation
10%
Adverse Event
9%
Malignant Neoplasm
9%
Blood Product
9%
Bone Marrow Transplantation
9%
Prevalence
8%
Von Willebrand Factor
7%
Clinician
7%
Major Bleeding
6%
Immunotherapy
6%
Serositis
6%
Intubation
6%
Cancer Immunotherapy
6%
Coagulopathy
6%
Stem Cell Therapy
6%
Subgroup Analysis
6%
Neurologic Disease
6%